Health-care companies slipped after reports of an inquiry into the business practices of the largest U.S. health insurer by enrollees.
UnitedHealth Group slid after The Wall Street Journal reported that the Department of Justice was probing the insurance giant's Medicare billing practices. The company, which had already faced a public backlash over its coverage practices, strongly disputed the report.
Among rivals, shares of health insurer Humana and pharmaceutical middle man CVS fell in sympathy.
Novo Nordisk shares rose after the U.S. Food and Drug Administration indicated a shortage of the Danish obesity-drug maker's Wegovy and Ozempic drugs had eased.
Shares of online pharmacy Hims & Hers, which had advertised an Ozempic substitute, plunged in the wake of the report.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
February 21, 2025 18:03 ET (23:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。